ID   USZ20-ESOS1
AC   CVCL_D4AB
SY   UniversitatsSpital Zurich 2020-ExtraSkeletal OsteoSarcoma 1
DR   Wikidata; Q127384626
RX   PubMed=37951844;
CC   Characteristics: Maintained as a sarco-sphere (PubMed=37951844).
CC   Doubling time: 5.8 days (PubMed=37951844).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3299; EIF5 + HGNC; HGNC:12629; USP6; Name(s)=EIF5-USP6 (PubMed=37951844).
CC   Derived from site: Metastatic; Skin, dermis; UBERON=UBERON_0002067.
ST   Source(s): PubMed=37951844
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 27,30
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 12,14
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8810; Extraskeletal osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37951844; DOI=10.1007/s13577-023-01001-6; PMCID=PMC10764462;
RA   Harnisch K.J., Steiner S., Pliego-Mendieta A., Chen Y.-J., Planas-Paz L.,
RA   Pauli C.;
RT   "Establishment and functional testing of a novel ex vivo extraskeletal
RT   osteosarcoma cell model (USZ20-ESOS1).";
RL   Hum. Cell 37:356-363(2024).
//